Income Statement

Currency: USD

	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024
Revenue
Revenue	57 N/A	51 -10%	92 +78%	125 +36%	147 +18%	146 -1%	100 -31%	71 -29%	44 -38%	46 +3%	38 -17%
Gross Profit
Cost of Revenue	(5)	(13)	(17)	(31)	(31)	(29)	(17)	(16)	(15)	(16)	(18)
Gross Profit	52 N/A	39 -25%	75 +93%	94 +25%	116 +24%	117 +1%	83 -29%	55 -34%	29 -47%	30 +2%	20 -34%
Operating Income
Operating Expenses	(343)	(334)	(328)	(313)	(311)	(301)	(300)	(266)	(212)	(169)	(118)
Selling, General & Administrative	(89)	(85)	(80)	(76)	(79)	(72)	(69)	(61)	(52)	(52)	(44)
Research & Development	(254)	(248)	(249)	(237)	(232)	(229)	(231)	(206)	(162)	(119)	(77)
Other Operating Expenses	(0)	(0)	(0)	(0)	(0)	(0)	(0)	2	2	2	2
Operating Income	(292) N/A	(295) -1%	(254) +14%	(220) +13%	(195) +11%	(184) +6%	(217) -18%	(211) +3%	(183) +13%	(139) +24%	(99) +29%
Pre-Tax Income
Interest Income Expense	0	2	3	5	8	10	12	13	13	12	11
Non-Reccuring Items	(10)	(10)	(10)	(4)	0	(21)	(21)	(26)	(34)	(13)	(17)
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	(5)	43	43	43
Total Other Income	17	11	6	4	7	11	8	6	4	3	4
Pre-Tax Income	(284) N/A	(292) -3%	(254) +13%	(215) +15%	(180) +16%	(184) -2%	(218) -18%	(223) -3%	(156) +30%	(95) +39%	(57) +39%
Net Income
Tax Provision	0	0	0	0	0	0	0	0	0	0	0
Income from Continuing Operations	(284)	(292)	(254)	(215)	(180)	(184)	(218)	(223)	(156)	(95)	(57)
Net Income (Common)	(284) N/A	(292) -3%	(254) +13%	(215) +15%	(180) +16%	(184) -2%	(218) -18%	(223) -3%	(156) +30%	(95) +39%	(57) +39%
EPS (Diluted)	-7.4 N/A	-7.47 -1%	-7.13 +5%	-4.95 +31%	-3.53 +29%	-3.59 -2%	-4.42 -23%	-4.28 +3%	-2.84 +34%	-1.8 +37%	-1.1 +39%

2Seventy Bio Inc
NASDAQ:TSVT